Psoriasis is a chronic autoimmune disease that causes skin cells to build up rapidly, resulting in itchy, red, scaly patches of skin. The psoriasis drugs market refers to the market for drugs used to treat this condition. The global psoriasis drugs market is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of psoriasis, the development of novel drugs, and the growing adoption of biologics in the treatment of psoriasis.
Worldwide sales of psoriasis drugs amounted to around US$ 11.37 Bn in 2021. The global psoriasis drugs market is predicted to progress at a CAGR of 6.5% to reach a valuation of US$ 21.48 Bn by 2031.
| Psoriasis Drugs Market Size (2021) | US$ 11.37 Bn |
| Projected Market Value (2031) | US$ 21.48 Bn |
| Global Market Growth Rate (2022-2031) | 6.5% CAGR |
| Market Share of Top 3 Countries | 35.6% |
Request For Free Sample Report of “Psoriasis Drugs Market”@ https://www.persistencemarketresearch.com/samples/25102
The global psoriasis drugs market is expected to grow at a significant rate during the forecast period, driven by factors such as increasing prevalence of psoriasis, growing acceptance of biologics as a treatment option, and increasing R&D in the field.
The market is segmented based on drug class, route of administration, and region. On the basis of drug class, the market is segmented into biologics, small molecules, and others. On the basis of route of administration, the market is segmented into oral and injectable. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Companies
- Janssen Biotech, Inc.
- Novartis International Ltd.
- Amgen Inc
- Pfizer Inc.
- Takeda Pharmaceutical Company Ltd.
- Merck & Co, Inc.
- Abb Vie Inc.
- Eli Lilly and Company
- Boehringer Ingelheim GmbH
- Sun Pharmaceutical Industries Ltd
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/25102
The major players operating in the psoriasis drugs market include AbbVie Inc., Amgen Inc, Celgene Corporation, Janssen Biotech, Inc., and others. These players have adopted various strategies, such as partnerships, collaborations, and new product launches, to increase their share in the market.
In conclusion, the global psoriasis drugs market is expected to grow at a significant rate during the forecast period, driven by factors such as increasing prevalence of psoriasis, growing acceptance of biologics as a treatment option, and increasing R&D in the field. The major players operating in the market are focusing on strategies such as partnerships, collaborations, and new product launches to increase their share in the
Competitive Landscape
Leading manufacturers of psoriasis drugs are focusing on launching new products and promoting their brands in order to gain maximum market share.
To boost product penetration, psoriasis medication manufacturers are focused on new marketing strategies. Companies continue to see approval and product launch as a critical component of their growth strategy. They are also concentrating on developing a value chain for major regional market, as well as developing new psoriasis drugs and long-term solutions.
For instance:
In February 2021, Amgen announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Otezla® (apremilast) for the treatment of adults with mild-to-moderate plaque psoriasis.
In April 2021, AbbVie announced that it has submitted applications seeking approval for SKYRIZI® (risankizumab-rzaa, 150 mg) to the U.S. Food and Drug Administration (FDA), and for SKYRIZI® (risankizumab, 150 mg) to the European Medicines Agency (EMA), for the treatment of adults with active psoriatic arthritis.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/25102
Key Segments Covered in Psoriasis Drugs Industry Research
Psoriasis Drugs Market by Product:
Topical Psoriasis Drugs
Oral Psoriasis Drugs
Injectable Psoriasis Drugs
Psoriasis Drugs Market by Drug Class:
Interleukin Inhibitors
Corticosteroids
Anti-inflammatory
Tumor Necrosis Factor Inhibitors
Psoriasis Drugs Market by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
e-Commerce
Psoriasis Drugs Market by Indication:
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
Erythrodermic Psoriasis
Plaque Psoriasis
For More Premium Insights, Check out the Link:
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com